Connect with us
Prague Gaming & TECH Summit 2025 (25-26 March)

Blockchain Press Releases

Clinical Trial Imaging Market worth $1.9 billion | MarketsandMarkets

Published

on

clinical-trial-imaging-market-worth-$1.9-billion-|-marketsandmarkets

CHICAGO, Aug. 18, 2023 /PRNewswire/ — In the near future, the Clinical Trial Imaging industry is poised to undergo a transformative evolution, driven by rapid advancements in medical imaging technology, data analytics, and regulatory frameworks. Cutting-edge imaging modalities such as functional MRI, molecular imaging, and advanced PET-CT scans will enable researchers to delve deeper into the intricacies of disease progression and treatment response, providing more nuanced and personalized insights. Integration of artificial intelligence and machine learning algorithms will streamline image analysis, facilitating quicker and more accurate diagnoses, patient stratification, and endpoint determination. Additionally, seamless collaboration between pharmaceutical companies, research institutions, and imaging facilities, coupled with standardized protocols, will enhance data sharing and accelerate clinical trial timelines. However, this expansion will also bring challenges in terms of data security, protocol harmonization, and ensuring the reliability of novel imaging techniques. In essence, the Clinical Trial Imaging industry’s imminent future promises to revolutionize the landscape of medical research, enhancing the efficiency and effectiveness of drug development while ultimately benefiting patient outcomes.

Clinical Trial Imaging Market in terms of revenue was estimated to be worth $1.3 billion in 2023 and is poised to reach $1.9 billion by 2028, growing at a CAGR of 7.8% from 2023 to 2028 according to a new report by MarketsandMarkets™. Rising expenditures in research and development, the expansion of the pharmaceutical and biotechnology sectors, and the proliferation of Contract Research Organizations (CROs) constitute several additional factors. Emerging economies like China, India, and Japan present attractive prospects for stakeholders engaged in the clinical trial imaging market.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=30446624

Browse in-depth TOC on “Clinical Trial Imaging Market”

111 – Tables
38 – Figures
179 – Pages

Advertisement

Clinical Trial Imaging Market Scope:

Report Coverage

Details

Market Revenue in 2023

$1.3 billion

Advertisement

Estimated Value by 2028

$1.9 billion

Growth Rate

Poised to grow at a CAGR of 7.8%

Market Size Available for

Advertisement

2021–2028

Forecast Period

2023–2028

Forecast Units

Value (USD Billion)

Advertisement

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Segments Covered

Service & software, modality, therapeutic area, end user and region

Geographies Covered

Advertisement

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Report Highlights

Updated financial information / product portfolio of players

Key Market Opportunities

Growth opportunities in emerging economies

Advertisement

Key Market Drivers

Rise in research and development expenditures

 

The services segment accounted for the largest share of the clinical trial imaging market, by product and service segment, in 2022

Based on product, the clinical trial imaging market is segmented into services and software. In 2022, services accounted for the largest share of the global clinical trial imaging market. The large share of this segment can primarily be attributed to the high cost of imaging equipment, which has driven the outsourcing of imaging clinical trials by pharmaceutical, biotechnology, and medical device manufacturers to service providers.

Advertisement

Positron emission tomography segment to register the highest growth rate during the forecast period

The clinical trial imaging market is segmented into computed tomography, magnetic resonance imaging, ultrasound, positron emission tomography, X-ray, echocardiography and other modalities. In 2022, the positron emission tomography segment accounted for the highest growth rate. Technological expansions and the introduction of new tracers for cardiology, oncology, and neurology applications are expected to support the adoption of PET systems in clinical trial settings.

The oncology segment accounted for the largest share of the clinical trial imaging market, by therapeutic area segment, in 2022

Based on therapeutic area, the clinical trial imaging market has been segmented into oncology, infectious diseases, neurology, CVS, endocrinology, immunological disorder and other therapeutic area. In 2022, the oncology segment accounted for the largest share of the clinical trial imaging market. The dominant portion of this segment’s market share can be chiefly attributed to the extensive volume of oncology-related clinical trials, driven by the global increase in cancer incidence.

North America is the largest regional market for clinical trial imaging market

Advertisement

The global clinical trial imaging market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the largest share of the clinical trial imaging market. The large share of this region can be attributed to the growing cutting-edge medical technologies, a mounting count of pharmaceutical and biotechnology enterprises, and substantial governmental investments in clinical research and development.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=30446624

Clinical Trial Imaging Market Dynamics:

Drivers:

  1. Increasing R&D spending
  2. Growth of pharmaceutical and biotechnology industries
  3. Increasing number of CROs

Restraints:

  1. High implementation cost of imaging systems

Opportunities:

  1. Growth opportunities in emerging economies
  2. Development of innovative imaging modalities, contrast agents, molecular probes, and radiopharmaceuticals

Challenges:

  1. High cost of clinical trials

Key Market Players:

The major players operating in this market are ICON plc. (Ireland), BioTelemetry Inc. (US), Biomedical Systems Corporation (US), Medpace Holdings, Inc. (US), IXICO plc. (UK), Resonance Health Ltd. (Australia), Radiant Sage LLC. (US), BioClinica Inc. (US), Intrinsic Imaging LLC. (US), Cardiovascular Imaging Technologies LLC. (US), Medical Metrics Inc. (US), Prism Clinical Imaging, Inc. (US), Boston Imaging Core Lab LLC. (US), anagram 4 clinical trials (Spain), Lyscaut Medical Imaging Company (Belgium), Calyx Group (UK), Bioseptive Inc. (Canada), ProScan Imaging LLC. (US), Micron Inc. (Japan), Imaging Endpoints LI, LLC (US), Perspectum Ltd. (UK), Pharmtrace klinische Entwicklung GmbH (Germany), WorldCare Clinical, LLC (US), Median Technologies (France) and Invicro. LLC. (US).

Advertisement

Recent Developments:

  • In March 2023, ICON Plc. (Ireland) announced a strategic partnership with LEO Pharma (Denmark) to scale clinical trial execution that is patient-centric and cost effective, and which will support the company’s overall ambition of building one of the most effective and efficient clinical portfolio execution organisations in the industry.
  • In March 2023, Clario (US), announced the launch of a cutting-edge cloud-based image viewer tool for sponsors and contract research organizations to view images related to their clinical trials.
  • In May 2021 IXICO Plc. (UK) signed a contract with biopharmaceutical client IXICO to provide neuroimaging services for a Phase III clinical trial under this contract.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=30446624

Clinical Trial Imaging Market Advantages:

  • Enhanced Decision Making: Imaging technologies allow researchers and clinicians to visualize biological processes and disease progression in real-time. This enables more informed decision-making during clinical trials by providing objective and quantifiable data on treatment efficacy and safety.
  • Early Endpoint Identification: Imaging enables the identification of early treatment responses and disease progression markers, enabling the early determination of trial endpoints. This leads to quicker assessment of treatment outcomes and potential for adaptive trial designs.
  • Patient-Centric Approach: Imaging modalities like PET scans, MRIs, and CT scans provide a non-invasive way to monitor patient health, reducing the need for invasive procedures. This patient-centric approach improves participant comfort and compliance in clinical trials.
  • Personalized Medicine: Advanced imaging techniques facilitate the identification of patient subgroups that respond better to specific treatments. This leads to the development of targeted therapies, enhancing treatment effectiveness and minimizing adverse effects.
  • Efficient Drug Development: Imaging accelerates drug development by providing insights into a drug’s mechanism of action and its impact on disease pathways. This reduces the time and costs associated with traditional trial endpoints, contributing to faster market entry for new drugs.
  • Objective Quantification: Imaging offers objective measurements of treatment effects, reducing subjectivity in data interpretation. This improves the robustness and credibility of trial results, enhancing the likelihood of regulatory approval.
  • Global Collaboration: Digital imaging technology allows real-time sharing of data across geographical boundaries, facilitating collaboration among researchers, clinicians, and regulatory agencies. This leads to standardized protocols and increased harmonization across clinical trials.
  • Regulatory Compliance: Well-established imaging techniques adhere to rigorous regulatory standards, ensuring the safety and ethical considerations of participants. This instills confidence in trial outcomes and supports regulatory approval processes.
  • Longitudinal Monitoring: Imaging enables researchers to track disease progression and treatment response over time, providing insights into the long-term effects of interventions. This information is crucial for understanding chronic diseases and evaluating treatment durability.
  • Translational Research: Clinical trial imaging bridges the gap between preclinical research and human studies, allowing researchers to validate findings in real-world patient populations. This aids in the translation of promising preclinical discoveries into effective clinical interventions.

In summary, the advantages of the Clinical Trial Imaging market lie in its ability to provide objective, precise, and timely data, enhancing the efficiency and success rate of drug development while ultimately benefiting patient care and medical advancements.

Related Reports:

CRO Services Market – Global Forecasts to 2028

Mice Model Market – Global Forecasts to 2028

Advertisement

Clinical Trial Supplies Market – Global Forecasts to 2028

Contrast Media Market – Global Forecasts to 2027

Diagnostic Imaging Market – Global Forecasts to 2026

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Advertisement

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/clinical-trials-imaging-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/clinical-trials-imaging.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

Advertisement

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/clinical-trial-imaging-market-worth-1-9-billion–marketsandmarkets-301904364.html

Continue Reading
Advertisement

Blockchain Press Releases

MEXC Report: Memecoins Made Almost 50% of New Token Listings In February

Published

on

mexc-report:-memecoins-made-almost-50%-of-new-token-listings-in-february

VICTORIA, Seychelles, March 13, 2025 /PRNewswire/ — MEXC, the leading global cryptocurrency exchange, has released token listing and trading data for January and February, highlighting strong market demand for new tokens, particularly memecoins, despite overall market volatility and downturn.

Key Takeaways:

  • Meme coins accounted for 50% of all new tokens listed in January and February.
  • Seven out of the top 10 tokens by trading volume were launched in February, highlighting continuous demand for promising listings despite market volatility.
  • The average peak increase for new tokens jumped from 388% in January to 660% in February, with TST surging by 4,792% and ELONSOL rising by 1,128%.
  • Four of the five best-performing tokens — TST, ELONSOL, MELANIA, and CAR — were linked to public figures, driven by the power of social trends.
  • TRUMP accounted for over 45% of the total trading volume for new tokens.

The report covers 451 new tokens listed on MEXC between January and February, with memecoins accounting for approximately 50% (245 tokens). This trend reflects the growing investor appetite for community-driven and viral digital assets.

The findings reflect the growing investor appetite for community-driven assets. Among the top 10 new tokens by trading volume, seven were launched in February, demonstrating sustained demand for high-profile listings despite a more subdued overall market trend in January.

February outperformed January in terms of average peak increases for new tokens, with the figure climbing from 388% to 660%. TST led the surge, reaching a staggering 4,792% increase, with ELONSOL following at 1,128%. The top 10 new tokens by trading volume recorded an average peak increase of 756%, underscoring the high level of trader interest and market activity.

Celebrity and politically themed memecoins demonstrated significant price surges, with four of the top five best-performing tokens — TST, ELONSOL, MELANIA, and CAR — linked to public figures. The top three memecoins (TST, ELONSOL, and MELANIA) recorded an average peak increase of 2,338%, compared to 640% for the top three non-meme tokens (BSX, J, and RIZ).

The TRUMP token was a dominant force in the market, accounting for over 45% of the total trading volume for new tokens. It attracted significant market liquidity and investor interest, strengthening its position as a top-performing asset.

MEXC’s latest data highlights the continued demand for trendy tokens and social trends, with meme coins driving trading activity. The dominance of meme coins in listings and their record-breaking price surges highlight MEXC’s position as a leading exchange for discovering and trading early digital assets. As the exchange remains committed to supporting innovations and trends, its deep liquidity and diverse listings offer traders unique opportunities in the fast-moving digital asset space.

For more details, please visit link.

Advertisement

About MEXC

Founded in 2018, MEXC is committed to being “Your Easiest Way to Crypto”. Serving over 34 million users across 170+ countries, MEXC is known for its broad selection of trending tokens, frequent airdrop opportunities, and low trading fees. Our user-friendly platform is designed to support both new traders and experienced investors, offering secure and efficient access to digital assets. MEXC prioritizes simplicity and innovation, making crypto trading more accessible and rewarding.

For more information, visit: MEXC WebsiteXTelegramHow to Sign Up on MEXC

Photo – https://mma.prnewswire.com/media/2641008/1920×1080.jpg
Photo – https://mma.prnewswire.com/media/2641005/1.jpg
Photo – https://mma.prnewswire.com/media/2641006/2.jpg
Photo – https://mma.prnewswire.com/media/2641007/3.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/mexc-report-memecoins-made-almost-50-of-new-token-listings-in-february-302400939.html

Advertisement
Continue Reading

Blockchain Press Releases

HTX Ventures: DeepSeek Triggers AI’s “iPhone Moment”, Accelerating AI Agents into Real Crypto Use

Published

on

htx-ventures:-deepseek-triggers-ai’s-“iphone-moment”,-accelerating-ai-agents-into-real-crypto-use

SINGAPORE, March 13, 2025 /PRNewswire/ — HTX Ventures recently released its latest research report, titled “DeepSeek Ignites AI’s ‘iPhone Moment’ as Agent Tokens Integrate into Real-World Crypto.” The report explores how DeepSeek’s use of pure reinforcement learning (RL) is transforming AI’s role in the crypto industry by boosting AI capabilities and cutting costs.

DeepSeek’s Emergence: AI-Powered Innovation Triggers Industry Transformation

In Q4 2024, the market saw a surge in top-tier AI Agents projects backed by Launchpads, driving a wave of asset issuance and quickly attracting capital and users. However, as the ICO rush began to subside, the hype in the AI Agents space had run its course. The market now urgently needed a catalyst to reignite growth.

DeepSeek’s breakthrough technology leverages pure reinforcement learning (RL) to enhance AI’s reasoning capabilities while significantly reducing costs. This advancement positions AI as a more effective partner for real-world applications, transforming the AI Agent sector. This progress could breathe new life into the Agent field and reshape the industry landscape.

The research report heralds DeepSeek’s debut as the “iPhone Moment” of the AI sector. Much like how the iPhone revolutionized the smartphone market, DeepSeek’s innovative technology is poised to lead a new era of crypto-tech development over the next few years.

Advertisement

The Unique Value and Accelerating Growth of AI Agents

The AI Agents ecosystem consists of four main sectors:

  • AI Agent Frameworks: These serve as the core infrastructure for the AI Agents ecosystem, lowering development barriers and accelerating AI’s application. The Eliza project stands out with its technical innovations and sustainable business model.
  • AI launchpads serve as hybrid incubators and trading platforms in the crypto space, lowering entry barriers for AI Agent projects and accelerating their launch, funding, and promotion.
  • AI Agent meme coins, which blend AI and meme narratives, have strong potential to go viral, making them effective tools for rapid capital accumulation. Examples include BULLY from the Virtual ecosystem and TAOCAT and LLM from the Bittensor ecosystem.
  • AI Agent applications focus on the implementation and commercialization of the technology in real-world scenarios, covering areas such as automated trading, asset management, market analysis, and cross-chain interaction. Representative projects are GRIFFAIN, NEUR, and BUZZ. AI Agent applications are expected to become the most promising segment in the sector.

The report emphasizes that deep expertise and resilience are vital for the success of AI Agent teams. Teams like Virtual, SEKOIA, ai16z, and Swarm have proven this through their perseverance and dedication. Additionally, product usability is a critical factor in driving user adoption and widespread acceptance in the crypto market.

2025: The Maturation of Crypto Combining with Agents, Where Revenue and User Adoption Drive Value

As the AI Agents market matures, it’s transitioning from a narrative-driven phase to one where value is based on data and revenue. The success of AI Agent projects will no longer be dictated by hype or the founding team’s pedigree but by their ability to achieve sustainable profitability and address real user needs through innovation.

Directions that deserve future attention:

Advertisement
  • Multi-Agent Systems and DeFAI (Decentralized Finance + AI): These sectors showcase AI’s tremendous potential for complex decision-making and financial automation, signaling long-term growth.
  • Core Framework Updates: It’s essential to monitor the ongoing evolution of critical frameworks like Eliza and ARC, as their upgrades could create entirely new applications and business models.
  • New Infrastructure Projects: AI models, data layers, and computing infrastructure tailored for the crypto ecosystem will be foundational to supporting the next-gen AI Agent ecosystem.

As a leading investment institution, HTX Ventures has consistently aligned its strategy with market trends. From backing DeepSeek to supporting AI Agents tokens, HTX Ventures sees tremendous potential in the synergy between AI and blockchain technologies, investing and positioning itself for the next wave of innovation. As AI and crypto technology converge, more opportunities and challenges knock. HTX Ventures is committed to driving further technical advancements, helping shape the future of the industry.

Read the full report here:https://square.htx.com/wp-content/uploads/2025/03/deepseek-triggers-ais-iphone-moment-accelerating-ai-agents-into-real-crypto-use.pdf

About HTX Ventures

HTX Ventures is the global investment arm of HTX, integrating investment, incubation, and research to identify and discover the best and most innovative projects in the market. Visit us here.

Feel free to contact us for investment and collaboration at [email protected]

Photo – https://mma.prnewswire.com/media/2640863/image_838145_14757924.jpg

Advertisement

Cision View original content:https://www.prnewswire.co.uk/news-releases/htx-ventures-deepseek-triggers-ais-iphone-moment-accelerating-ai-agents-into-real-crypto-use-302400781.html

Continue Reading

Blockchain Press Releases

DeriW Testnet Launch Sets New Standards in Decentralized Derivatives Trading

Published

on

deriw-testnet-launch-sets-new-standards-in-decentralized-derivatives-trading

HONG KONG, March 13, 2025 /PRNewswire/ — DeriW, the world’s first zero-gas-fee decentralized perpetual exchange operated by CoinW, has officially launched its public testnet, marking a pivotal step toward a new era of DeFi derivatives trading. This testnet isn’t a generic trial run – it’s a full-featured preview of DeriW’s high-performance, user-centric platform, designed to demonstrate concrete improvements in usability, speed, and security. Early users and developers can now experience lightning-fast trades, up to 100x leverage, and robust security measures in a realistic environment as DeriW prepares to challenge industry incumbents.

A Closer Look at the Testnet: Usability, Performance & Security

DeriW’s testnet is engineered to feel like a production-ready exchange. Usability is key: traders can quickly connect their self-custody wallets and begin trading cryptocurrencies like Bitcoin and Ethereum with up to 100x leverage and a low 0.02% transaction fee. The platform offers multiple order types (market, limit, take-profit, stop-loss) and a diverse selection of tokens, from major assets to emerging projects. With its zero gas fee model, DeriW eliminates blockchain transaction costs, enabling rapid order placement and frictionless trading—comparable to centralized exchanges.

On the performance front, the DeriW testnet showcases the platform’s cutting-edge infrastructure. Built on the Arbitrum Orbit Layer 3 network (DeriW Chain), it leverages optimistic rollup technology and a custom WASM/Geth-based architecture. In practical terms, this translates to extremely high throughput and low latency. With a capacity of up to 80,000 transactions per second, testnet traders can execute orders smoothly with minimal latency, ensuring the platform stays responsive even during intense trading activity.

Security measures are woven deeply into the testnet’s design, reflecting DeriW’s priority on protecting users. By building on Arbitrum’s L3, DeriW inherits Ethereum’s battle-tested security properties and decentralization while adding its own enhancements. All trades and collateral remain on-chain under users’ self-custody, eliminating the custodial risks found in centralized exchanges. To further harden the platform, DeriW launched a comprehensive bug bounty program in tandem with the testnet. Security researchers and users are incentivized with bounties ranging from 100 to 100,000 $DER tokens for identifying vulnerabilities. Additionally, the testnet operates with a closed-fund liquidity mechanism and an automatic risk recalibration system that ensure stability even under extreme market conditions. These concrete measures give testnet participants confidence that the platform’s performance comes without compromising safety.

Advertisement

How DeriW Stacks Up

In an increasingly competitive DeFi derivatives arena, DeriW’s testnet is already demonstrating unique advantages over other leading platforms’ test networks:

  • Gas Fees & Trading Costs: DeriW distinguishes itself with its zero gas fee model. Every trade on DeriW’s testnet is executed without on-chain transaction fees, which is a stark contrast to many competitors. DeriW’s approach of truly on-chain, gas-free trading gives it an edge in user experience – traders get the convenience of a CEX-like feel without sacrificing on-chain transparency.
  • Performance Throughput: When it comes to raw speed, DeriW sets a high bar, delivering up to ~80,000 TPS—exceptional among decentralized exchanges. In comparison, some newer standalone-chain DEXs offer around 10,000 TPS—better than legacy Ethereum-based platforms but only an eighth of DeriW’s capability. This firmly places DeriW among elite, next-generation exchanges that support high-frequency trading at scale. Notably, DeriW achieves this impressive throughput while remaining fully EVM-compatible and secured by Ethereum, powered by the Arbitrum Orbit framework—a key differentiator validated by real user conditions on its testnet.
  • Leverage and Trading Features: High leverage is a hallmark of derivative exchanges, and DeriW doesn’t disappoint. It offers up to 100x leverage on major trading pairs, which is higher than most decentralized competitors. By providing 100x, DeriW is catering to a segment of traders who seek higher risk-reward profiles, similar to offerings on some centralized futures exchanges. Importantly, DeriW couples this with advanced order types (stop-loss, take-profit, etc.) on the testnet, ensuring traders have tools to manage the risk that comes with high leverage. This combination of flexibility and control is critical – and DeriW is showing that even in a testnet environment, users can practice sophisticated trading strategies that rival those on established platforms.
  • Liquidity Model & Price Execution: Perhaps the most innovative aspect differentiating DeriW is its Pendulum AMM liquidity pool. Unlike traditional order books or static AMMs with oracles, DeriW’s pool dynamically adjusts liquidity based on traders’ positions. This “pendulum” approach optimizes asset utilization in real-time, supporting volumes beyond initial capital, reducing slippage, and providing deeper liquidity. While orderbook-based DEXs rely on market makers—vulnerable to slippage during volatility—DeriW’s closed-fund model and automatic risk recalibration ensure solvency and stability, combining order-book depth with AMM efficiency.
  • Security and Decentralization: All leading DeFi derivatives platforms prioritize security but use different approaches. Some rely on decentralized validators, others utilize their own consensus mechanisms with federated validators, and another inherits security from Arbitrum Layer 2. DeriW leverages Ethereum’s robust security via Arbitrum’s rollup, enhanced by its unique UBPK (Unstolen Browser Private Key) mechanism that ensures private keys remain securely stored within user browsers.

Benchmarks and Performance Metrics in Context

Thanks to Arbitrum Orbit’s efficient consensus and block production, DeriW’s block time is expected to be on the order of a second or less, which is similar to other DEXs 0.2s block time advantage. Achieving near-instant finality is crucial for traders who might otherwise worry about timing and MEV (Maximal Extractable Value) issues. Although detailed latency stats are still being gathered, the user experience goal is clear: make on-chain trading on DeriW feel as immediate as trading on a centralized platform.

Another important metric is uptime and reliability during the test. The DeriW team is closely monitoring system uptime and recovery from any crashes or network issues. A robust exchange must handle network spikes, degraded conditions, or attacks without downtime. By publishing these performance metrics and comparing them with industry standards, DeriW intends to demonstrate transparently where it stands. So far, the absence of gas fees and high throughput capacity on testnet have enabled continuous trading even when simulating thousands of concurrent users – something that might clog less scalable testnets. The platform is also tracking how its automatic risk controls (like the pendulum mechanism) perform quantitatively: e.g., maintaining targeted liquidity levels, keeping slippage near zero, and ensuring the funding rates and PnL (profit and loss) for liquidity providers stay within expected bounds. These technical benchmarks, once validated on testnet, will serve as proof points that DeriW can handle real-world volumes and stress when it goes live.

Expected Outcomes & Next Steps Before Mainnet Launch

Advertisement

The testnet phase is not just a demo for DeriW – it’s a critical period for learning and refining. The main goals include collecting user feedback on the trading interface and features, uncovering any bugs or security vulnerabilities, and optimizing the platform’s performance under realistic conditions.

DeriW is actively analyzing user interactions with its new liquidity model (including preferred leverage levels, popular trading pairs, and responses to zero fees) to refine fee structures and risk management. Incentive initiatives, such as the Supernova event, serve both as promotional tools and practical stress tests to ensure the platform performs reliably under high trading volume.

Feedback collected through community channels will directly guide improvements, prioritizing user-identified issues in ongoing development sprints. By Q2 2025, DeriW plans to transition from testnet to mainnet alongside the $DER Token Generation Event (TGE), officially launching its economic and governance models. Prior to mainnet launch, the team will thoroughly fine-tune smart contracts, bolster infrastructure, and enhance the user interface based on insights gained from testnet users.

The roadmap beyond mainnet is ambitious: by Q3 2025, DeriW plans to introduce a professional-grade API for algorithmic traders and support custom trading pairs. By Q4 2025, the goal is to cultivate a global trading community and further improve the user experience through community-driven enhancements—all built upon the foundation established during the testnet.

Engaging the Community and Conclusion

Advertisement

DeriW actively keeps the community engaged and informed with regular testnet updates, transparent performance metrics, and ongoing social media interaction. Early testnet adopters gain not only rewards but also valuable firsthand experience, positioning them advantageously for the mainnet launch. Backed by the seasoned CoinW exchange group, the meticulous approach to this testnet demonstrates readiness for prime time.

DeriW’s testnet isn’t just another generic launch—it’s a bold demonstration of innovation, combining proven DeFi strengths with fresh enhancements. By benchmarking against industry leaders, DeriW signals its ambition to lead in decentralized trading. The coming months will be critical, but current progress suggests DeriW is well-positioned to convert testnet success into a transformative mainnet launch. Stay tuned as DeriW moves from testnet to mainnet, carrying forward the insights and confidence gained during this trial by fire.

About DeriW  

DeriW is the first zero-gas-fee decentralized perpetual contract exchange, blending Ethereum’s security with Layer 3 scalability to deliver CEX-like efficiency in a decentralized framework. Operated by CoinW’s seasoned fintech team, it redefines trading with 80,000 TPS throughput, ensuring speed, transparency, and trustless execution.   

Website: www.deriw.com 
Twitter: @deriwfi 
Telegram: https://t.me/deriwfinance
Discord: https://discord.com/invite/deriwfinance 

Advertisement
Safe & Secure Crypto Exchange - CoinW

Photo – https://mma.prnewswire.com/media/2639829/DeriW_Testnet_Launch_Sets_New_Standards_Decentralized_Derivatives_Trading.jpg
Logo – https://mma.prnewswire.com/media/2618621/CoinW_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/deriw-testnet-launch-sets-new-standards-in-decentralized-derivatives-trading-302400740.html

Continue Reading
Advertisement
 title=
Advertisement

Latest News

Recent Listings

  • Global Payout, Inc.

    Since the Company’s inception in 2009, Global Payout, Inc. has been a leading provider of compreh...

  • MTrac Tech Corp.

    MTrac Tech Corporation, a Nevada Corporation, is a privately held, wholly owned subsidiary of Glo...

  • Net1

    Net1 is a leading provider of transaction processing services, financial inclusion products ...

  • uBUCK Technologies SEZC

    Based in Georgetown, Cayman Islands, uBUCK Tech is a fintech enterprise that specializes in digit...

  • LiteLink Technologies Inc.

      LiteLink is a major player in developing world-class enterprise platforms that utilize ar...

  • Good Gamer Corp.

      Good Gamer Corp. is a privately-held technology company focusing on gamers and streamers....

  • BitPay

      Founded in 2011, BitPay pioneered blockchain payment processing with the mission of trans...

  • About Net1

      Net1 is a leading provider of transaction processing services, financial inclusion produc...

  • Blockchain Foundry Inc.

    Headquartered in Toronto, Canada, Blockchain Foundry (CSE:BCFN)(FWB:8BF)(OTC:BLFDF) is a global b...

  • Sixgill

    Sixgill provides a full suite of universal data automation and authenticity products and services...

Trending on TBE